Ingredients Insider - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients Insider

Fluorination Remains Key Challenge in API Synthesis

October 2, 2014

Pharmaceutical Technology

Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.

Asymmetric Synthesis Continues to Advance

September 2, 2014

Pharmaceutical Technology

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

August 2, 2014

Pharmaceutical Technology

Customers are looking to reduce risk, increase performance, and optimize productivity.

No Signs of a Slowdown in Mergers

August 1, 2014

Pharmaceutical Technology Europe

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

The Mainstreaming of Continuous Flow API Synthesis

July 2, 2014

Pharmaceutical Technology

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Seeking Alternative Catalyst Solutions

June 2, 2014

Pharmaceutical Technology

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

May 2, 2014

Pharmaceutical Technology

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

April 2, 2014

Pharmaceutical Technology

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

March 2, 2014

Pharmaceutical Technology

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here